Bone-Breaking News: Mayo Clinic Solves Mysterious Link Between Diabetes and Osteoporosis
SANTA BARBARA, Calif., Nov. 14, 2013 /PRNewswire-iReach/ -- Mayo Clinic, the world's leading medical center, discovered bone deterioration is yet another complication of diabetes. The discovery was enabled by a new medical device, OsteoProbe®, developed by Active Life Scientific, Inc. in Santa Barbara, California.
OsteoProbe® is designed to measure the material properties of bone as a signature of bone strength, and as a target for new treatments and disease prevention. A growing body of scientific evidence is attracting an A-list of global customers and collaborators to the medical value of the company's novel technology.
"We congratulate Dr. Khosla and his top-notch team for this vital contribution to medical knowledge," says Davis Brimer, Active Life Chief Executive Officer. "These important findings further validate the significance of material properties to bone strength."
"This is the first demonstration – using direct measurement of bone strength in the body – of compromised bone material in patients with type 2 diabetes," says Sundeep Khosla, M.D., Mayo Clinic endocrinologist, senior author of the study.
It is known that a patient with diabetes has a higher fracture risk than a non-diabetic, what is not known is why. The gold-standard method for diagnosing fracture risk is a bone density scan to determine how much bone there is, however that method is ineffective because diabetics have the same bone density as non-diabetics. The study suggests a deterioration of bone material properties may indicate a greater risk of fracture.
About Active Life
Active Life Scientific, Inc. is enabling cutting edge science and technology to help people live a long and active life. Their flagship products, OsteoProbe® and BioDent™, are being used worldwide by the most innovative and thought leading scientists and physicians working hard to extend your active life. The company's technology introduces unrivaled direct measures of the health of tissues in patients before deteriorating and negatively impacting quality of life. The Company's products are based on world renowned inventor Professor Paul Hansma's latest breakthrough, Reference Point Indentation. www.activelifescientific.com
About Mayo Clinic
Media Contact: Jennifer Rios, Active Life Scientific, Inc., +1.805.770.2600 x102, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Active Life Scientific, Inc.